Boaz Weinstein’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-27,728
| Closed | -$183 | – | 408 |
|
|
2026
Q1 | $183 | Hold |
27,728
| – | – | ﹤0.01% | 390 |
|
|
2025
Q4 | $3K | Hold |
27,728
| – | – | ﹤0.01% | 335 |
|
|
2025
Q3 | $5.77K | Hold |
27,728
| – | – | ﹤0.01% | 301 |
|
|
2025
Q2 | $6.17K | Hold |
27,728
| – | – | ﹤0.01% | 293 |
|
|
2025
Q1 | $5.98K | Sell |
27,728
-2,207
| -7% | -$732 | ﹤0.01% | 239 |
|
|
2024
Q4 | $12.3K | Hold |
29,935
| – | – | ﹤0.01% | 241 |
|
|
2024
Q3 | $5.54K | Hold |
29,935
| – | – | ﹤0.01% | 309 |
|
|
2024
Q2 | $6.22K | Hold |
29,935
| – | – | ﹤0.01% | 336 |
|
|
2024
Q1 | $3.13K | Hold |
29,935
| – | – | ﹤0.01% | 373 |
|
|
2023
Q4 | $11.2K | Hold |
29,935
| – | – | ﹤0.01% | 408 |
|
|
2023
Q3 | $7.49K | Hold |
29,935
| – | – | ﹤0.01% | 514 |
|
|
2023
Q2 | $19K | Hold |
29,935
| – | – | ﹤0.01% | 499 |
|
|
2023
Q1 | $14.5K | Hold |
29,935
| – | – | ﹤0.01% | 666 |
|
|
2022
Q4 | $15.7K | Buy |
+29,935
| New | +$19.1K | ﹤0.01% | 763 |
|
Boaz Weinstein's SRTAW Position: Q2 2026 in Review
Boaz Weinstein sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2026, closing a stake of 27,728 shares — an estimated $183 sold.
Boaz Weinstein first reported a position in SRTAW in Q4 2022 and held it in 14 quarters. The position peaked at $19K in Q2 2023. 0 funds tracked by Wall St. Rank hold SRTAW as of Q2 2026.
- Boaz Weinstein reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2026 after selling out during the quarter.
- Boaz Weinstein sold 27,728 Strata Critical Medical Inc Warrants shares in Q2 2026, an estimated $183.
- Boaz Weinstein first reported a position in Strata Critical Medical Inc Warrants in Q4 2022 and held it in 14 quarters.
- Boaz Weinstein's Strata Critical Medical Inc Warrants position peaked at $19K in Q2 2023.
- 0 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2026.
Based on Saba Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.